Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1974 1
1978 1
1979 3
1980 2
1981 3
1982 2
1983 1
1984 4
1985 5
1986 3
1987 2
1988 5
1989 5
1990 11
1991 6
1992 19
1993 7
1994 10
1995 4
1996 10
1997 5
1998 5
1999 4
2000 7
2001 5
2002 2
2003 8
2004 3
2005 12
2006 12
2007 11
2008 7
2009 14
2010 19
2011 22
2012 26
2013 20
2014 21
2015 24
2016 21
2017 23
2018 22
2019 19
2020 26
2021 34
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

453 results
Results by year
Filters applied: . Clear all
Page 1
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.
Javle M, Roychowdhury S, Kelley RK, Sadeghi S, Macarulla T, Weiss KH, Waldschmidt DT, Goyal L, Borbath I, El-Khoueiry A, Borad MJ, Yong WP, Philip PA, Bitzer M, Tanasanvimon S, Li A, Pande A, Soifer HS, Shepherd SP, Moran S, Zhu AX, Bekaii-Saab TS, Abou-Alfa GK. Javle M, et al. Among authors: pande a. Lancet Gastroenterol Hepatol. 2021 Oct;6(10):803-815. doi: 10.1016/S2468-1253(21)00196-5. Epub 2021 Aug 3. Lancet Gastroenterol Hepatol. 2021. PMID: 34358484 Clinical Trial.
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial.
Makawita S, K Abou-Alfa G, Roychowdhury S, Sadeghi S, Borbath I, Goyal L, Cohn A, Lamarca A, Oh DY, Macarulla T, T Shroff R, Howland M, Li A, Cho T, Pande A, Javle M. Makawita S, et al. Among authors: pande a. Future Oncol. 2020 Oct;16(30):2375-2384. doi: 10.2217/fon-2020-0299. Epub 2020 Jun 25. Future Oncol. 2020. PMID: 32580579 Clinical Trial.
Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals.
Rhee C, Jones TM, Hamad Y, Pande A, Varon J, O'Brien C, Anderson DJ, Warren DK, Dantes RB, Epstein L, Klompas M; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Rhee C, et al. Among authors: pande a. JAMA Netw Open. 2019 Feb 1;2(2):e187571. doi: 10.1001/jamanetworkopen.2018.7571. JAMA Netw Open. 2019. PMID: 30768188 Free PMC article.
NO Network for Plant-Microbe Communication Underground: A Review.
Pande A, Mun BG, Lee DS, Khan M, Lee GM, Hussain A, Yun BW. Pande A, et al. Front Plant Sci. 2021 Mar 17;12:658679. doi: 10.3389/fpls.2021.658679. eCollection 2021. Front Plant Sci. 2021. PMID: 33815456 Free PMC article. Review.
Transposable elements and their identification.
Makałowski W, Pande A, Gotea V, Makałowska I. Makałowski W, et al. Among authors: pande a. Methods Mol Biol. 2012;855:337-59. doi: 10.1007/978-1-61779-582-4_12. Methods Mol Biol. 2012. PMID: 22407715 Review.
Intracranial epithelioid hemangioendothelioma.
Mohan S M, Symss NP, Pande A, Chakravarthy VM, Ramamurthi R. Mohan S M, et al. Among authors: pande a. Childs Nerv Syst. 2008 Jul;24(7):863-8. doi: 10.1007/s00381-008-0634-4. Epub 2008 May 14. Childs Nerv Syst. 2008. PMID: 18478237 Review.
453 results